| Vol. 13.02 – 22 January, 2021 |
| |
|
|
| Consistent with a driver oncogenic role, FYN–TRAF3IP2 expression in hematopoietic progenitors induced NF-κB-driven T-cell transformation in mice and cooperated with loss of the Tet2 tumor suppressor in peripheral T-cell lymphoma development. [Nature Cancer] |
|
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Scientists showed that in aging mice myeloid cell bioenergetics were suppressed in response to increased signaling by the lipid messenger prostaglandin E2, a major modulator of inflammation. [Nature] |
|
|
|
| Researchers showed that tumor-secreted protease cathepsin C promoted breast-to-lung metastasis by regulating recruitment of neutrophils and formation of neutrophil extracellular traps. [Cancer Cell] |
|
|
|
| Investigators discovered that T cell receptor antigen recognition increased in the left ventricle as cardiac dysfunction progressed. [Circulation] |
|
|
|
| To determine the states that CD4+ effector lymphocytes (Teff) cells actually adopt in frontline tissues in vivo, scientists applied single-cell transcriptome and chromatin analyses to colonic Teff cells in germ-free or conventional mice. [Nature Immunology] |
|
|
|
| The authors found that γδ T cell subsets making either interferon-γ or interleukin-17 had intrinsically distinct metabolic requirements. [Nature Immunology] |
|
|
|
| Researchers combined the serial intravascular staining technique with single-cell RNA sequencing to dissect the tightly connected processes by which donor T cells initially infiltrate tissues and then established a pathogenic tissue residency program in a rhesus macaque allo-HCT model that develops acute graft-versus-host disease. [Science Translational Medicine] |
|
|
|
| Investigators found that IKKβ ubiquitination on lysine-238 was substantially increased during inflammation. Using mass spectrometry, they identified USP16 as an essential regulator of the IKKβ ubiquitination level that selectively affected p105 phosphorylation without directly affecting p65 or IκBα phosphorylation. [Science Advances] |
|
|
|
| Scientists showed that liver‐infiltrating dnTGFβRII CD8 T cells had significantly decreased levels of the miRNA biogenesis molecules P4ha1 and Ago2 along with significantly increased levels of granzyme B and perforin. [Hepatology] |
|
|
|
| The authors identified a novel enhancer of RORγt gene in Th17 cells, RORCE2. RORCE2 deficiency suppressed RORγt expression and Th17 differentiation, leading to reduced severity of experimental autoimmune encephalomyelitis. [Nature Communications] |
|
|
|
| Researchers developed two methods to inactivate mTOR, Raptor, or Rictor in early stage natural killer (NK) cells or in late-stage NK cells. They found that when mTOR was deleted by CD122-Cre during and after NK cell commitment, NK cell development was severely impaired. [Cell Death & Differentiation] |
|
|
|
| Using atg5-deficient and atg7-/- macrophages, scientists provide evidence that loss of ATG5 but not of ATG7 resulted in LC3-II depletion. [Autophagy] |
|
|
|
|
| The authors review the current clinical advances and experimental findings supporting the utility of an anti-inflammatory approach to the treatment of solid malignancies. [Nature Reviews Clinical Oncology] |
|
|
|
| Scientists discuss novel approaches to overcome the key challenges associated with CD3+ bispecific T-cell redirection in order to achieve an optimal balance of anti-tumor activity and safety. [British Journal of Cancer] |
|
|
|
|
| NantKwest, Inc. and ImmunityBio, Inc. announced early interim results of its PD-L1 t-haNK protocols showing median survival rates more than doubled that of the historic rate in patients with advanced metastatic pancreatic cancer for which no other FDA-approved treatment exists. [NantKwest, Inc.] |
|
|
|
|
|
|
|
| Stanford School of Medicine – Stanford, California, United States |
|
|
|
| University of Luxembourg – Luxembourg City, Luxembourg |
|
|
|
| Cleveland Clinic – Cleveland, Ohio, United States |
|
|
|
| Dana-Farber Cancer Institute – Boston, Massachusetts, United States |
|
|
|
| NIH National Cancer Institute – Bethesda, Maryland, United States |
|
|
|
|